Target intelligence / Profile preview

Centruroides noxius neurotoxins (CnTx)

Target
CnTx
Molecular classification
Scorpion venom neurotoxin, Voltage-gated sodium channel modifier, Alpha-scorpion toxin family
01

Overview

Centruroides noxius neurotoxins are a group of potent peptides found in the venom of the Mexican bark scorpion, one of the most dangerous scorpion species in Mexico [UniProt P01491]. These toxins, particularly the alpha-toxins like Cn1, primarily target voltage-gated sodium channels (Nav) in the nervous system [PubMed: 11566114]. By binding to neurotoxin receptor site 3 on the sodium channel, they slow down the inactivation process, leading to prolonged depolarization and repetitive firing of neurons [PubChem CID 11953901]. This physiological disruption results in severe clinical symptoms known as scorpionism, characterized by autonomic dysfunction, neuromuscular hyperactivity, and potentially fatal respiratory failure [StatPearls]. In a clinical context, these toxins serve as the primary targets for specific antivenom therapies, such as Alacramyn, which utilize antibody fragments to sequester the toxins and prevent their binding to host ion channels [FDA: Anascorp Label]. The toxins are highly specific, with some variants showing preference for mammalian channels while others target insect channels, making them significant subjects in neuropharmacological research [UniProt P01487]. Effective management of envenomation relies on the rapid administration of these antivenoms to neutralize the toxins before irreversible binding occurs.

Other names
Cn1 toxinCn2 toxinMexican bark scorpion neurotoxinsCentruroides alpha-toxinsSodium channel modifier toxins
02

Mechanism of action

Antivenoms consist of venom-specific F(ab')2 fragments that bind to and neutralize the circulating neurotoxins, preventing their interaction with voltage-gated sodium channels and facilitating their clearance from the systemic circulation [PubMed: 19446558].

03

Biological functions

Inhibition of sodium channel inactivationProlongation of action potentialsInduction of neurotransmitter release
04

Disease associations

Scorpion envenomationNeurotoxicityAutonomic storm
05

Safety considerations

Hypersensitivity reactionsAnaphylaxisSerum sickness [FDA]
06

Interacting drugs

Centruroides immune F(ab')2 (equine)

2 more in the full profile.

07

Biomarkers

Serum toxin concentrationClinical signs of envenomation (e.g., nystagmus, fasciculations) [StatPearls]

Beyond the preview

Go deeper on Centruroides noxius neurotoxins (CnTx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centruroides noxius neurotoxins (CnTx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call